0001179110-11-015315.txt : 20111117 0001179110-11-015315.hdr.sgml : 20111117 20111117162910 ACCESSION NUMBER: 0001179110-11-015315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111115 FILED AS OF DATE: 20111117 DATE AS OF CHANGE: 20111117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EYLENBOSCH HILDE CENTRAL INDEX KEY: 0001272540 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16789 FILM NUMBER: 111213317 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: C/O INVERNESS MEDICAL INNOVATIONS INC CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALERE INC. CENTRAL INDEX KEY: 0001145460 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043565120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7816473900 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC DATE OF NAME CHANGE: 20010720 4 1 edgar.xml FORM 4 - X0304 4 2011-11-15 0 0001145460 ALERE INC. ALR 0001272540 EYLENBOSCH HILDE 51 SAWYER ROAD, SUITE 200 WALTHAM 02453 0 1 0 0 Chief Commercial Officer Common Stock 2011-11-15 4 M 0 17229 15.47 A 47365 D Common Stock 2011-11-15 4 S 0 17229 26.024 D 30136 D Common Stock 43143 I Spouse Common Stock 3248 D Employee Stock Option (Right to Buy) 15.47 2011-11-15 4 M 0 17229 D 2011-11-30 Common Stock 17229 0 D These options became exercisable in four equal annual installments beginning 11/30/2002. This derivative security does not have a price. This reporting person disclaims beneficial ownership of the reported securities. These securities are jointly owned with the reporting person's spouse. Represents the weighted average purchase price. Securities were sold through approximately 114 separate block trades executed on the Transaction Date at an average price of $26.024. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected. The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options. /s/ Jay McNamara, Attorney in Fact 2011-11-17